(I know the answer, but) Why would the death of a single person from a clinical trial freeze an entire category of funding? Surely, many people die in clinical trials of other types of medicine (caused by the treatment) and that doesn't cause the trials to be shut down. Immunotherapy of cancer wouldn't be a viable treatment if subjected to the same level of regulation as gene therapy.